Company · CIK 921299
KYNTRA BIO, INC.
| CIK | 921299 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | CA |
| Listed | KYNB (Nasdaq) |
| First annual or quarterly report | 2015-03-26 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-280597 | 2024-06-28 | 2025-02-24 | 3 | |
| 333-266663 | 2022-08-08 | 2023-02-27 | 2 | |
| 333-236844 | 2020-03-02 | 2020-03-02 | 1 | |
| 333-216368 | 2017-03-01 | 2017-08-16 | 4 | |
| 333-199069 | 2014-10-01 | 2014-11-14 | 8 |
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-02-24 | 424B5Shelf takedown | 333-280597 | 0001193125-25-033535 |
| 2024-07-10 | EFFECTDeclared effective | 333-280597 | 9999999995-24-002117 |
| 2024-06-28 | S-3Shelf registered | 333-280597 | 0001193125-24-172413 |
| 2023-02-27 | 424B5Shelf takedown | 333-266663 | 0001193125-23-050860 |
| 2022-08-08 | S-3ASRShelf registered | 333-266663 | 0001193125-22-215039 |
| 2020-03-02 | S-3ASRShelf registered | 333-236844 | 0001193125-20-059227 |
| 2017-08-16 | 424B5Shelf takedown | 333-216368 | 0001193125-17-259680 |
| 2017-08-15 | 424B5Shelf takedown | 333-216368 | 0001193125-17-257582 |
| 2017-04-06 | 424B5Shelf takedown | 333-216368 | 0001193125-17-113816 |
| 2017-03-01 | S-3ASRShelf registered | 333-216368 | 0001193125-17-065756 |
| 2014-11-14 | 424B4Final prospectus | 333-199069 | 0001193125-14-413231 |
| 2014-11-13 | EFFECTDeclared effective | 333-199069 | 9999999995-14-003353 |
| 2014-11-12 | S-1/AAmendment | 333-199069 | 0001193125-14-406755 |
| 2014-10-30 | S-1/AAmendment | 333-199069 | 0001193125-14-387925 |
| 2014-10-24 | S-1/AAmendment | 333-199069 | 0001193125-14-381669 |
| 2014-10-23 | S-1/AAmendment | 333-199069 | 0001193125-14-380087 |
| 2014-10-20 | S-1/AAmendment | 333-199069 | 0001193125-14-375408 |
| 2014-10-01 | S-1Registration filed | 333-199069 | 0001193125-14-359619 |
| 2014-06-11 | DRSDraft made public | 377-00651 | 0000950123-14-006724 |